Daily Roundup
Thursday, 30th January 2025
Last updated: 21:00
CCA.ASX MIN.ASX ALC.ASX BIO.ASX KAR.ASX
Positive Momentum Across Aussie Stocks
It's been a busy day on the Australian markets, with several companies reporting strong quarterly results and strategic moves.
Change Financial Exits US, Focuses on Profitable Growth Change Financial (ASX: CCA) has delivered an impressive performance in Q2 FY25, with customer receipts up 103% to US$3.7 million and revenue increasing 53% to US$3.5 million. The company's H1 FY25 revenue reached US$7.2 million, with 76% coming from recurring streams. However, Change Financial has made the strategic decision to exit its loss-making US operations to improve its overall financial performance. This move is expected to drive a substantial improvement in EBITDA and cashflow from H2 FY25 onwards.
Mineral Resources Maintains Guidance, Transitions Bald Hill Mineral Resources (ASX: MIN) has reported a solid quarter, with its Onslow Iron project progressing towards its 35 million tonnes per annum run rate. The company has maintained its FY25 guidance for all continuing operations, despite transitioning its Bald Hill operation into care and maintenance amid market conditions. Mineral Resources' liquidity remains strong, with $1.5 billion in cash and undrawn facilities.
Alcidion Delivers Strong Sales and Cash Flows Alcidion Group (ASX: ALC) has also had a productive quarter, reporting Q2 new sales of $13.1 million in total contract value, with $4.5 million of that revenue expected to be recognized in FY25. The company's Q2 cash receipts reached $9.1 million, with an operating cash outflow of only $0.26 million - a significant improvement over the prior corresponding period. Alcidion remains on track to be EBITDA and cashflow positive in FY25.
Biome Australia Sees Positive Results for Probiotic Strain In other news, Biome Australia (ASX: BIO) has received positive results from its studies on the functional characteristics of its probiotic strain BMB18. The in-vitro studies demonstrated the strain's ability to modulate immune responses, reduce oxidative stress, and maintain intestinal barrier integrity, presenting significant potential for new product development and broadening the use of existing products.
Karoon Energy Announces Additional Share Buybacks Rounding out the day's announcements, Karoon Energy (ASX: KAR) plans to undertake an additional US$75 million of on-market share buybacks over the 2025 calendar year, on top of the current US$25 million program. This is part of the company's 2025 Capital Returns Plan, which also includes semi-annual shareholder distributions.
Overall, it's been a positive day for the Australian market, with several companies showcasing strong operational and financial performance, strategic initiatives, and promising research and development outcomes.
References
CCA.ASX | 08:23 | Quarterly Activities/Appendix 4C Cash Flow Report |
MIN.ASX | 08:18 | Quarterly Activity Report - Q2 FY25 |
ALC.ASX | 08:22 | Q2 FY25 Quarterly Activities Report and Appendix 4C |
BIO.ASX | 08:24 | Positive Results on Clinical Development of BMB18 |
KAR.ASX | 09:27 | Additional US$75m buyback |